Related Experiment Video
Updated: May 17, 2026
11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
[Rizatriptan-induced liver toxicity. Report of a case]
Alberto Fernandez-Atutxa1, Mercedes Vergara, Montserrat Gil
1Servicio de Digestivo, Corporación Sanitaria Parc Taulí, Universidad Autónoma de Barcelona, España. afernandeza@tauli.cat
Gastroenterologia Y Hepatologia
|October 23, 2012
Summary
Rizatriptan, a common migraine medication, has been linked to liver damage in a new case report. This finding is significant as liver toxicity is rare for this drug class.
Area of Science:
- Pharmacology
- Hepatology
- Neurology
Background:
- Triptans are widely used for acute migraine treatment.
- Sumatriptan was the first triptan, followed by several derivatives.
- Hepatotoxicity is a rare but serious adverse effect associated with some medications.
Observation:
- A case of liver injury potentially caused by rizatriptan is presented.
- This is only the second reported instance of triptan-induced liver toxicity.
- The patient experienced adverse effects after taking rizatriptan for migraine.
Findings:
- Rizatriptan, a serotonin 5-HT1B/1D receptor agonist, can cause hepatotoxicity.
- The clinical presentation and potential mechanisms of rizatriptan-induced liver injury are discussed.
- This case highlights the importance of monitoring liver function in patients taking triptans.
Implications:
- Clinicians should be aware of the potential for rizatriptan-induced liver toxicity.
- Further research is needed to understand the incidence and risk factors for triptan-related hepatotoxicity.
- This finding may influence prescribing guidelines and patient counseling for migraine treatments.
Related Concept Videos
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...